Burson Cohn & Wolfe on Behalf of Astrazeneca Pharmaceuticals LP
Biopharmaceutical company
Based in DE
AI Overview
With $330K in lobbying spend across 5 quarterly filings, Burson Cohn & Wolfe on Behalf of Astrazeneca Pharmaceuticals LP is an active lobbying client. They deploy 11 individual lobbyists Their lobbying covers 3 issue areas. Active from 2020 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $0 |
| 2021 | $330K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Burson Cohn & Wolfe on Behalf of Astrazeneca Pharmaceuticals LP disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Trade, Health Issues
COVID-19 vaccine and therapy development
Intellectual property issues
COVID-19 vaccine development, manufacturing, and distribution
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.